Hyemin Jang

Body Mass Index and Mortality Rate in Korean Patients with Alzheimer's Disease.

Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke.

Correlations between Gray Matter and White Matter Degeneration in Pure Alzheimer's Disease, Pure Subcortical Vascular Dementia, and Mixed Dementia.

Prediction Model of Conversion to Dementia Risk in Subjects with Amnestic Mild Cognitive Impairment: A Longitudinal, Multi-Center Clinic-Based Study.

Diagonal Earlobe Crease is a Visible Sign for Cerebral Small Vessel Disease and Amyloid-β.

Prognostic value of amyloid PET scan in normal pressure hydrocephalus.

Head to head comparison of [F] AV-1451 and [F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia.

Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy.

The Impact of APOE ɛ4 in Alzheimer's Disease Differs According to Age.

Author Correction: Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy.

Assessment of Extent and Role of Tau in Subcortical Vascular Cognitive Impairment Using 18F-AV1451 Positron Emission Tomography Imaging.

Total MRI Small Vessel Disease Burden Correlates with Cognitive Performance, Cortical Atrophy, and Network Measures in a Memory Clinic Population.

Amyloid involvement in subcortical regions predicts cognitive decline.

Social Event Memory Test (SEMT): A Video-based Memory Test for Predicting Amyloid Positivity for Alzheimer's Disease.

Vascular Effects on Depressive Symptoms in Cognitive Impairment.

Trajectories of Physiological Brain Aging and Related Factors in People Aged from 20 to over-80.

A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.

Distinct amyloid distribution patterns in amyloid positive subcortical vascular cognitive impairment.

Cortical atrophy pattern-based subtyping predicts prognosis of amnestic MCI: an individual-level analysis.

Cerebrospinal fluid from Alzheimer's disease patients as an optimal formulation for therapeutic application of mesenchymal stem cells in Alzheimer's disease.

Multimodal imaging analyses in patients with genetic and sporadic forms of small vessel disease.

Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals.

Clinical significance of amyloid β positivity in patients with probable cerebral amyloid angiopathy markers.

Clinical Effects of Frontal Behavioral Impairment: Cortical Thickness and Cognitive Decline in Individuals with Subjective Cognitive Decline and Amnestic Mild Cognitive Impairment.

Analysis of dementia-related gene variants in APOE ε4 noncarrying Korean patients with early-onset Alzheimer's disease.

Distinct Brain Regions in Physiological and Pathological Brain Aging.

Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T).

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers.

Sex-specific relationship of cardiometabolic syndrome with lower cortical thickness.

THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report.

Application of an amyloid and tau classification system in subcortical vascular cognitive impairment patients.

Amyloid and cerebrovascular burden divergently influence brain functional network changes over time.

Author Correction: Non-alcoholic fatty liver disease and cerebral small vessel disease in Korean cognitively normal individuals.

Author Correction: Multimodal imaging analyses in patients with genetic and sporadic forms of small vessel disease.

The Cortical Neuroanatomy Related to Specific Neuropsychological Deficits in Alzheimer's Continuum.

Differences in neuroimaging features of early- versus late-onset nonfluent/agrammatic primary progressive aphasia.

A new Centiloid method for F-florbetaben and F-flutemetamol PET without conversion to PiB.

Presynaptic dopaminergic function in early-onset Alzheimer's disease: an FP-CIT image study.

Reduced forced vital capacity is associated with cerebral small vessel disease burden in cognitively normal individuals.

Clinical significance of focal ß-amyloid deposition measured by F-flutemetamol PET.

Frontal-executive dysfunction affects dementia conversion in patients with amnestic mild cognitive impairment.

Correction to: A new Centiloid method for F-florbetaben and F-flutemetamol PET without conversion to PiB.

Intrathecal Injection in A Rat Model: A Potential Route to Deliver Human Wharton's Jelly-Derived Mesenchymal Stem Cells into the Brain.

Heterogeneous Disease Progression in a Mouse Model of Vascular Cognitive Impairment.

Identifying a subtype of Alzheimer's disease characterised by predominant right focal cortical atrophy.

Head-to-Head Comparison of 18F-Florbetaben and 18F-Flutemetamol in the Cortical and Striatal Regions.

Optical coherence tomography angiography as a potential screening tool for cerebral small vessel diseases.

Exploring the Potential of Mesenchymal Stem Cell-Based Therapy in Mouse Models of Vascular Cognitive Impairment.

The preclinical amyloid sensitive composite to determine subtle cognitive differences in preclinical Alzheimer's disease.

Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients.

The Effects of Longitudinal White Matter Hyperintensity Change on Cognitive Decline and Cortical Thinning over Three Years.

Appropriate reference region selection of F-florbetaben and F-flutemetamol beta-amyloid PET expressed in Centiloid.

Association between ε2 and Aβ burden in patients with Alzheimer- and vascular-type cognitive impairment.

The Impact of Amyloid-β or Tau on Cognitive Change in the Presence of Severe Cerebrovascular Disease.

Disease progression modeling of Alzheimer's disease according to education level.

Prediction of amyloid β PET positivity using machine learning in patients with suspected cerebral amyloid angiopathy markers.

Concordance in detecting amyloid positivity between F-florbetaben and F-flutemetamol amyloid PET using quantitative and qualitative assessments.

Strictly Lobar Microbleeds Reflect Amyloid Angiopathy Regardless of Cerebral and Cerebellar Compartments.

Cerebrospinal Fluid Biomarkers for the Diagnosis and Classification of Alzheimer's Disease Spectrum.

Machine Learning for the Prediction of Amyloid Positivity in Amnestic Mild Cognitive Impairment.